These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria. Kessel A, Bishara R, Amital A, Bamberger E, Sabo E, Grushko G, Toubi E. Clin Exp Allergy; 2005 Feb; 35(2):221-5. PubMed ID: 15725195 [Abstract] [Full Text] [Related]
33. [Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in the urine of children with pyelonephritis]. Tenderenda E, Zoch-Zwierz W, Wasilewska A, Porowski T, Taranta-Janusz K, Kołodziejczyk Z, Michaluk-Skutnik J. Pol Merkur Lekarski; 2009 Jul; 27(157):10-3. PubMed ID: 19650421 [Abstract] [Full Text] [Related]
36. Matrix metalloproteinases and their tissue inhibitors in children with chronic hepatitis B treated with lamivudine. Lebensztejn DM, Skiba E, Sobaniec-Łotowska ME, Kaczmarski M. Adv Med Sci; 2007 Jul; 52():114-9. PubMed ID: 18217401 [Abstract] [Full Text] [Related]
37. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome. Gonçalves FM, Jacob-Ferreira AL, Gomes VA, Casella-Filho A, Chagas AC, Marcaccini AM, Gerlach RF, Tanus-Santos JE. Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704 [Abstract] [Full Text] [Related]